Search results
Novavax failed to capitalize on fears surrounding mRNA vaccines, activist investor says
Market Watch· 2 weeks agoHedge fund Shah Capital on Monday called for an “urgent shake up” at the board of Novavax over...
Novavax investor Shah Capital pushes for board shakeup
Reuters· 2 weeks agoThe hedge fund nominated Suresh Katta, founder and CEO of biotech firm Saama, and Venkat Peri, CEO...
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
Motley Fool via Yahoo Finance· 5 days agoAmtagvi's approval means that Iovance should soon start reporting its first product revenue. That...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 2 days agoNow, shares are below that ceiling. It will be important to watch how Pfizer stock performs as the...
12 Most Shorted Stocks in 2024
Insider Monkey via Yahoo Finance· 7 days agoIn this article, we will take a detailed look at the 12 Most Shorted Stocks in 2024. For a quick overview of such stocks, read our article 5 Most Shorted...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 2 days agoA Phase 3 study is already underway with the initial results expected later this decade. But at...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 4 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
What's in Store for Biogen (BIIB) This Earnings Season?
Zacks via Yahoo Finance· 7 days agoBiogen's (BIIB) sales in the first quarter are likely to have been hurt by lower sales of its...